Dave Spaight

Dave Spaight

Investitore di Private Equity presso
Arsenal Capital Management LP
Finance
Consumer Services
Commercial Services

Profilo

Mr. Spaight is an Operating Partner of Arsenal for the healthcare team.
Prior to joining Arsenal in 2016, Mr. Spaight served as the Chairman and CEO of WIL Research Laboratories, a leading pre-clinical (“CRO”) acquired by Charles River Laboratories.
Prior to WIL, he served as President of MDS Pharma Services, a global CRO serving all phases of pharmaceutical research and development, from early discovery to late-stage clinical trials and central laboratory support.
Prior to MDS, he held senior leadership positions in Fisher Scientific Products and PerkinElmer.

Posizioni attive di Dave Spaight

SocietàPosizioneInizio
Investitore di Private Equity 01/08/2016

Precedenti posizioni note di Dave Spaight

SocietàPosizioneFine
Presidente 31/12/2010
Investitore di Private Equity 31/12/2005
Vedi nel dettaglio l'esperienza di Dave Spaight

Formazione di Dave Spaight

Esperienze
Posizioni ricoperte

Attive

Inattive

Società nel listino

Aziende private

Relazioni

96

Relazioni di 1° grado

4

Aziende connesse in 1º grado

Uomo

Donna

Amministratori

Dirigenti

Società collegate

Aziende private4

Finance

Consumer Services

Commercial Services

Health Technology

  1. Mercati
  2. Insiders
  3. Dave Spaight